The journal Pharmacogenomics, published by Future Medicine, part of UK-based Future Science Group, is celebrating its 100th issue this year.
The key objective of the peer-reviewed journal has been to provide a forum for multidisciplinary scientists to keep abreast of the latest developments in this field, and to provide commentary and analysis to place these advances in context. Pharmacogenomics is currently published monthly (12 issues per year) by Future Medicine. The journal will increase its frequency to 16 issues per year in 2012.
Senior Editors Dr Howard McLeod (University of North Carolina, USA), Prof. Munir Pirmohamed (University of Liverpool, UK) and Dr David Gurwitz (Tel Aviv University, Israel) drive the editorial direction of Pharmacogenomics. The Senior Editors are supported by a team of Associate Editors, together with an advisory panel of more than fifty international experts.
To celebrate this milestone issue, the top 10 most viewed articles published in Pharmacogenomics over the last decade are being made free to access for 2 weeks. These articles are assessable from www.future-science-group.com/m/360.
Search for more Pharmacology related STM journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
